Latest News and Press Releases

The pharmaceutical suppositories market size is projected to reach USD 13.4 billion by 2034 from its value of USD 9.5 billion in 2024, at a CAGR of 3.5%

LONDON, May 06, 2026 (GLOBE NEWSWIRE) -- First Quarter Financial Highlights. On May 6, 2026, pursuant to the Company's capital return policy (the "Capital Return Policy"), the Board of Directors...

TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX®, its latest innovation in...

GROWTH IN THREE OF FOUR DIVISIONS & IMPROVEMENTS IN MULTIPLE KEY FINANCIAL METRICS FIRST QUARTER NET INCOME OF $7.3 MILLION, UP $4.4 MILLION YEAR-OVER-YEAR FIRST QUARTER ADJUSTED EBITDA MARGIN...

Revenue increased 87.4% year-over-year to $67.4 million in Q1 2026Logistics revenue and gross profit grew 32.4% and 29.9% year-over-year, respectively, in Q1 2026, which represents Strata's organic...

Strong Experiential Services performance and improved Retailer Services profitability drove Adjusted EBITDA growth Centralized labor model implementation continues to enhance execution, productivity,...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and...

Strong Revenue Growth of 4.6%Expansion in Gross Profit Margin of 120 Basis PointsGAAP Net Income of $2.4 million and Earnings Per Diluted Share of $0.07 Adjusted EBITDA of $14.3 million, an increase...

WESTFORD, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) reported its financial results for the first quarter ended April 4, 2026. First Quarter Financial Highlights Bookings...

Revenue of $3.3 billion, up 10.8% year over year, with organic revenue growth of 4.1%$227 million of new business wins across key verticals, with approximately 40% in strategic growth sectors —...